Found 587 results
Type [ Year(Asc)]
N Strash, S DeLuca, Janer G Carattini, Y Chen, J Scherba, M Jain, R Naseri, T Wu, and N Bursac. "BRAF-V600E-Mediated Erk Activation Promotes Sustained Cell Cycling and Broad Transcriptional Changes in Neonatal Cardiomyocytes." (2022).
S DeLuca, and N Bursac. "CRISPR Library Screening in Cultured Cardiomyocytes." Methods in Molecular Biology (Clifton, N.J.) 2485 (2022): 1-13.
HX Nguyen, T Wu, D Needs, H Zhang, RM Perelli, S DeLuca, R Yang, M Tian, AP Landstrom, C Henriquez et al. "Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy." Nature Communications 13, no. 1 (2022).
V Janbandhu, V Tallapragada, R Patrick, Y Li, D Abeygunawardena, DT Humphreys, EMMA Martin, AO Ward, O Contreras, N Farbehi et al. "Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction." Cell Stem Cell 29, no. 2 (2022): 281-297.e12.
J Wang, T Broer, T Chavez, CJ Zhou, S Tran, Y Xiang, A Khodabukus, Y Diao, and N Bursac. "Myoblast deactivation within engineered human skeletal muscle creates a transcriptionally heterogeneous population of quiescent satellite-like cells." Biomaterials 284 (2022): 121508.
JC Scherba, R Karra, JW Turek, and N Bursac. "Toward improved understanding of cardiac development and congenital heart disease: The advent of cardiac organoids." The Journal of Thoracic and Cardiovascular Surgery (2022).
Z Chen, B Li, R-Z Zhan, L Rao, and N Bursac. "Exercise mimetics and JAK inhibition attenuate IFN-γ-induced wasting in engineered human skeletal muscle." Science Advances 7, no. 4 (2021).
A Helfer, and N Bursac. "Frame-Hydrogel Methodology for Engineering Highly Functional Cardiac Tissue Constructs." Methods in Molecular Biology (Clifton, N.J.) 2158 (2021): 171-186.
N Strash, S DeLuca, GL Janer Carattini, SC Heo, R Gorsuch, and N Bursac. "Human Erbb2-induced Erk activity robustly stimulates cycling and functional remodeling of rat and human cardiomyocytes." Elife 10 (2021).
T Wu, HX Nguyen, and N Bursac. In vitro discovery of novel prokaryotic ion channel candidates for antiarrhythmic gene therapy.. Vol. 654., 2021.
R-Z Zhan, L Rao, Z Chen, N Strash, and N Bursac. "Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium." Acta Biomaterialia 126 (2021): 144-153.
Z Fralish, EM Lotz, T Chavez, A Khodabukus, and N Bursac. "Neuromuscular Development and Disease: Learning From in vitro and in vivo Models." Frontiers in Cell and Developmental Biology 9 (2021).
K Saha, EJ Sontheimer, PJ Brooks, MR Dwinell, CA Gersbach, DR Liu, SA Murray, SQ Tsai, RC Wilson, DG Anderson et al. "The NIH Somatic Cell Genome Editing program." Nature 592, no. 7853 (2021): 195-204.
B Arnson, J Wang, D Courtney, S-O Han, S Li, BR Cullen, N Bursac, and D Koeberl. "Single Vector AAV Approach to Genome Editing in Pompe Disease." In Molecular Therapy, 291. Vol. 29. 2021.
J Wang, CJ Zhou, A Khodabukus, S Tran, S-O Han, AL Carlson, L Madden, PS Kishnani, DD Koeberl, and N Bursac. "Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease." Communications Biology 4, no. 1 (2021).
JE Pomeroy, A Helfer, and N Bursac. "Biomaterializing the promise of cardiac tissue engineering." Biotechnol Adv 42 (2020).
T Broer, A Khodabukus, and N Bursac. "Can we mimic skeletal muscles for novel drug discovery?" Expert Opinion on Drug Discovery 15, no. 6 (2020): 643-645.
AB Sklivas, GD II, N Bursac, A Khodahukus, T Koves, D Muoio, L Madden, GA Truskey, WE Kraus, and MJ Hubal. "Gene Expression Differences In Three-dimensional Myobundles Compared To Two-dimensional Myocultures." In Medicine and Science in Sports and Exercise, 781-782. Vol. 52. 2020.
ME Kondash, A Ananthakumar, A Khodabukus, N Bursac, and GA Truskey. "Glucose Uptake and Insulin Response in Tissue-engineered Human Skeletal Muscle." Tissue Engineering and Regenerative Medicine 17, no. 6 (2020): 801-813.
N Strash, S DeLuca, Janer G Carattini, SC Heo, R Gorsuch, and N Bursac. "Human Erbb2-induced Erk Activity Robustly Stimulates Cycling and Functional Remodeling of Rat and Human Cardiomyocytes." (2020).
Y Li, D Song, L Mao, DM Abraham, and N Bursac. "Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure." Biomaterials 236 (2020).
A Khodabukus, A Kaza, J Wang, N Prabhu, R Goldstein, VS Vaidya, and N Bursac. "Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers." Toxicological Sciences 176, no. 1 (2020): 124-136.
S Sengupta, KE Rothenberg, H Li, BD Hoffman, and N Bursac. "Altering integrin engagement regulates membrane localization of Kir2.1 channels." Journal of Cell Science 132, no. 17 (2019).
JL Berry, W Zhu, YL Tang, P Krishnamurthy, Y Ge, JP Cooke, Y Chen, DJ Garry, H-T Yang, NS Rajasekaran et al. "Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure." Circulation Research 124, no. 1 (2019): 161-169.
A Khodabukus, L Madden, NK Prabhu, TR Koves, CP Jackman, DM Muoio, and N Bursac. "Electrical stimulation increases hypertrophy and metabolic flux in tissue-engineered human skeletal muscle." Biomaterials 198 (2019): 259-269.